FEATURED COMPANIES
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Berlin Heart GmbH
- CorWave SA
- Jarvik Heart Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Ventricular Assist Devices Market: About this market
The ventricular assist devices market analysis considers sales from left and right ventricular assist devices and bi-ventricular assist devices products. Our study also finds the sales of ventricular assist devices in Asia, Europe, North America, and ROW. In 2019, the left and right ventricular assist devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing prevalence of end-stage heart failure and rising number of new product launches will play a significant role in the left and right ventricular assist devices segment to maintain its market position. Also, our global ventricular assist devices market report looks at factors such as increasing prevalence of heart failure, new product launches, and scarcity of donor hearts for transplantation. However, high costs associated with ventricular assist devices, complications related to implantation of ventricular assist devices, and frequent product recalls may hamper the growth of the ventricular assist devices industry over the forecast period.
Global Ventricular Assist Devices Market: Overview
Increasing prevalence of heart failure
Patients who suffer from chronic cardiovascular diseases have a high risk of developing heart failure. Ischemic heart disease is found to be one of the most common causes of heart failure. Surgeons use implantable mechanical pumps such as ventricular assist devices in patients with heart failure or those with a weak heart muscle. In addition, the implantation of ventricular assist devices is also recommended for patients with congestive heart failure. Thus, the increasing prevalence of heart failure will lead to the expansion of the global ventricular assist devices market at a CAGR of almost 12% during the forecast period.
Technological advances
The procurement and maintenance of medical equipment account for a significant part of a healthcare organization's operational expenses. However, growing technological innovations have enabled a paradigm shift in the cost as well as the manageability of medical equipment. Technologically advanced and innovative ventricular assist devices are used to aid in cardiac circulation, which can partially or completely replace the function of the heart. Second-generation ventricular assist devices include implantable, continuous flow, rotary pumps with axial flow. Market vendors are also developing third-generation ventricular support devices that are incorporated with centrifugal continuous-flow pumps, which provide enhanced durability and reliability. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global ventricular assist devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ventricular assist devices manufacturers, that include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co. KGaA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.
Also, the ventricular assist devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The ventricular assist devices market analysis considers sales from left and right ventricular assist devices and bi-ventricular assist devices products. Our study also finds the sales of ventricular assist devices in Asia, Europe, North America, and ROW. In 2019, the left and right ventricular assist devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing prevalence of end-stage heart failure and rising number of new product launches will play a significant role in the left and right ventricular assist devices segment to maintain its market position. Also, our global ventricular assist devices market report looks at factors such as increasing prevalence of heart failure, new product launches, and scarcity of donor hearts for transplantation. However, high costs associated with ventricular assist devices, complications related to implantation of ventricular assist devices, and frequent product recalls may hamper the growth of the ventricular assist devices industry over the forecast period.
Global Ventricular Assist Devices Market: Overview
Increasing prevalence of heart failure
Patients who suffer from chronic cardiovascular diseases have a high risk of developing heart failure. Ischemic heart disease is found to be one of the most common causes of heart failure. Surgeons use implantable mechanical pumps such as ventricular assist devices in patients with heart failure or those with a weak heart muscle. In addition, the implantation of ventricular assist devices is also recommended for patients with congestive heart failure. Thus, the increasing prevalence of heart failure will lead to the expansion of the global ventricular assist devices market at a CAGR of almost 12% during the forecast period.
Technological advances
The procurement and maintenance of medical equipment account for a significant part of a healthcare organization's operational expenses. However, growing technological innovations have enabled a paradigm shift in the cost as well as the manageability of medical equipment. Technologically advanced and innovative ventricular assist devices are used to aid in cardiac circulation, which can partially or completely replace the function of the heart. Second-generation ventricular assist devices include implantable, continuous flow, rotary pumps with axial flow. Market vendors are also developing third-generation ventricular support devices that are incorporated with centrifugal continuous-flow pumps, which provide enhanced durability and reliability. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global ventricular assist devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ventricular assist devices manufacturers, that include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co. KGaA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.
Also, the ventricular assist devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Berlin Heart GmbH
- CorWave SA
- Jarvik Heart Inc.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Left and right ventricular assist devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Left and right ventricular assist devices - Year-over-year growth 2020-2024 (%)
Exhibit 22: Bi-ventricular assist devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Bi-ventricular assist devices - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Product recalls
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Business strategies and their market impact analysis
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abbott Laboratories - Vendor overview
Exhibit 48: Abbott Laboratories - Business segments
Exhibit 49: Abbott Laboratories - Organizational developments
Exhibit 50: Abbott Laboratories - Geographic focus
Exhibit 51: Abbott Laboratories - Segment focus
Exhibit 52: Abbott Laboratories - Key offerings
Exhibit 53: Abbott Laboratories - Key customers
Exhibit 54: Abiomed Inc. - Vendor overview
Exhibit 55: Abiomed Inc. - Business segments
Exhibit 56: Abiomed Inc. - Organizational developments
Exhibit 57: Abiomed Inc. - Geographic focus
Exhibit 58: Abiomed Inc. - Key offerings
Exhibit 59: Abiomed Inc. - Key customers
Exhibit 60: Asahi Kasei Corp. - Vendor overview
Exhibit 61: Asahi Kasei Corp. - Business segments
Exhibit 62: Asahi Kasei Corp. - Organizational developments
Exhibit 63: Asahi Kasei Corp. - Geographic focus
Exhibit 64: Asahi Kasei Corp. - Segment focus
Exhibit 65: Asahi Kasei Corp. - Key offerings
Exhibit 66: Asahi Kasei Corp. - Key customers
Exhibit 67: Berlin Heart GmbH - Vendor overview
Exhibit 68: Berlin Heart GmbH - Business segments
Exhibit 69: Berlin Heart GmbH - Key offerings
Exhibit 70: Berlin Heart GmbH - Key customers
Exhibit 71: CorWave SA - Vendor overview
Exhibit 72: CorWave SA - Business segments
Exhibit 73: CorWave SA - Organizational developments
Exhibit 74: CorWave SA - Key offerings
Exhibit 75: CorWave SA - Key customers
Exhibit 76: Fresenius Medical Care AG & Co. KGaA - Vendor overview
Exhibit 77: Fresenius Medical Care AG & Co. KGaA - Business segments
Exhibit 78: Fresenius Medical Care AG & Co. KGaA - Organizational developments
Exhibit 79: Fresenius Medical Care AG & Co. KGaA - Geographic focus
Exhibit 80: Fresenius Medical Care AG & Co. KGaA - Segment focus
Exhibit 81: Fresenius Medical Care AG & Co. KGaA - Key offerings
Exhibit 82: Fresenius Medical Care AG & Co. KGaA - Key customers
Exhibit 83: Jarvik Heart Inc. - Vendor overview
Exhibit 84: Jarvik Heart Inc. - Business segments
Exhibit 85: Jarvik Heart Inc. - Key offerings
Exhibit 86: Jarvik Heart Inc. - Key customers
Exhibit 87: LivaNova Plc - Vendor overview
Exhibit 88: LivaNova Plc - Business segments
Exhibit 89: LivaNova Plc - Organizational developments
Exhibit 90: LivaNova Plc - Geographic focus
Exhibit 91: LivaNova Plc - Segment focus
Exhibit 92: LivaNova Plc - Key offerings
Exhibit 93: LivaNova Plc - Key customers
Exhibit 94: Medtronic Plc - Vendor overview
Exhibit 95: Medtronic Plc - Business segments
Exhibit 96: Medtronic Plc - Organizational developments
Exhibit 97: Medtronic Plc - Geographic focus
Exhibit 98: Medtronic Plc - Segment focus
Exhibit 99: Medtronic Plc - Key offerings
Exhibit 100: Medtronic Plc - Key customers
Exhibit 101: Mohawk Innovative Technology Inc. - Vendor overview
Exhibit 102: Mohawk Innovative Technology Inc. - Product segments
Exhibit 103: Mohawk Innovative Technology Inc. - Key offerings
Exhibit 104: Mohawk Innovative Technology Inc. - Key customers
Exhibit 105: Validation techniques employed for market sizing
Exhibit 106: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market segmentation analysis
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Left and right ventricular assist devices - Market size and forecast 2019-2024
- Bi-ventricular assist devices - Market size and forecast 2019-2024
- Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Technological advances
- Growing number of mergers and acquisitions
- New products in the ventricular assist devices pipeline
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Berlin Heart GmbH
- CorWave SA
- Fresenius Medical Care AG & Co. KGaA
- Jarvik Heart Inc.
- LivaNova Plc
- Medtronic Plc
- Mohawk Innovative Technology Inc.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Left and right ventricular assist devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Left and right ventricular assist devices - Year-over-year growth 2020-2024 (%)
Exhibit 22: Bi-ventricular assist devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Bi-ventricular assist devices - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Product recalls
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Business strategies and their market impact analysis
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Abbott Laboratories - Vendor overview
Exhibit 48: Abbott Laboratories - Business segments
Exhibit 49: Abbott Laboratories - Organizational developments
Exhibit 50: Abbott Laboratories - Geographic focus
Exhibit 51: Abbott Laboratories - Segment focus
Exhibit 52: Abbott Laboratories - Key offerings
Exhibit 53: Abbott Laboratories - Key customers
Exhibit 54: Abiomed Inc. - Vendor overview
Exhibit 55: Abiomed Inc. - Business segments
Exhibit 56: Abiomed Inc. - Organizational developments
Exhibit 57: Abiomed Inc. - Geographic focus
Exhibit 58: Abiomed Inc. - Key offerings
Exhibit 59: Abiomed Inc. - Key customers
Exhibit 60: Asahi Kasei Corp. - Vendor overview
Exhibit 61: Asahi Kasei Corp. - Business segments
Exhibit 62: Asahi Kasei Corp. - Organizational developments
Exhibit 63: Asahi Kasei Corp. - Geographic focus
Exhibit 64: Asahi Kasei Corp. - Segment focus
Exhibit 65: Asahi Kasei Corp. - Key offerings
Exhibit 66: Asahi Kasei Corp. - Key customers
Exhibit 67: Berlin Heart GmbH - Vendor overview
Exhibit 68: Berlin Heart GmbH - Business segments
Exhibit 69: Berlin Heart GmbH - Key offerings
Exhibit 70: Berlin Heart GmbH - Key customers
Exhibit 71: CorWave SA - Vendor overview
Exhibit 72: CorWave SA - Business segments
Exhibit 73: CorWave SA - Organizational developments
Exhibit 74: CorWave SA - Key offerings
Exhibit 75: CorWave SA - Key customers
Exhibit 76: Fresenius Medical Care AG & Co. KGaA - Vendor overview
Exhibit 77: Fresenius Medical Care AG & Co. KGaA - Business segments
Exhibit 78: Fresenius Medical Care AG & Co. KGaA - Organizational developments
Exhibit 79: Fresenius Medical Care AG & Co. KGaA - Geographic focus
Exhibit 80: Fresenius Medical Care AG & Co. KGaA - Segment focus
Exhibit 81: Fresenius Medical Care AG & Co. KGaA - Key offerings
Exhibit 82: Fresenius Medical Care AG & Co. KGaA - Key customers
Exhibit 83: Jarvik Heart Inc. - Vendor overview
Exhibit 84: Jarvik Heart Inc. - Business segments
Exhibit 85: Jarvik Heart Inc. - Key offerings
Exhibit 86: Jarvik Heart Inc. - Key customers
Exhibit 87: LivaNova Plc - Vendor overview
Exhibit 88: LivaNova Plc - Business segments
Exhibit 89: LivaNova Plc - Organizational developments
Exhibit 90: LivaNova Plc - Geographic focus
Exhibit 91: LivaNova Plc - Segment focus
Exhibit 92: LivaNova Plc - Key offerings
Exhibit 93: LivaNova Plc - Key customers
Exhibit 94: Medtronic Plc - Vendor overview
Exhibit 95: Medtronic Plc - Business segments
Exhibit 96: Medtronic Plc - Organizational developments
Exhibit 97: Medtronic Plc - Geographic focus
Exhibit 98: Medtronic Plc - Segment focus
Exhibit 99: Medtronic Plc - Key offerings
Exhibit 100: Medtronic Plc - Key customers
Exhibit 101: Mohawk Innovative Technology Inc. - Vendor overview
Exhibit 102: Mohawk Innovative Technology Inc. - Product segments
Exhibit 103: Mohawk Innovative Technology Inc. - Key offerings
Exhibit 104: Mohawk Innovative Technology Inc. - Key customers
Exhibit 105: Validation techniques employed for market sizing
Exhibit 106: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Berlin Heart GmbH
- CorWave SA
- Jarvik Heart Inc.
The following companies as the key players in the global ventricular assist devices market: Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co. KGaA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances.”
According to the report, one of the major drivers for this market is the increasing prevalence of heart failure.
Further, the report states that one of the major factors hindering the growth of this market is the frequent product recalls.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances.”
According to the report, one of the major drivers for this market is the increasing prevalence of heart failure.
Further, the report states that one of the major factors hindering the growth of this market is the frequent product recalls.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Berlin Heart GmbH
- CorWave SA
- Fresenius Medical Care AG & Co. KGaA
- Jarvik Heart Inc.
- LivaNova Plc
- Medtronic Plc
- Mohawk Innovative Technology Inc.
Note: Product cover images may vary from those shown
LOADING...
